SpringerLink
Log in

Lacosamide in patients with gliomas and uncontrolled seizures: results from an observational study

  • Clinical Study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

To report the efficacy and tolerability of lacosamide as an add-on treatment in patients with gliomas and uncontrolled seizures despite conventional antiepileptic drugs (AEDs). We conducted an observational study on 71 patients to describe patterns of response to lacosamide and the association between clinico-pathological factors and seizure control. We observed at 3, 6 and 9 months a seizure reduction ≥ 50% in 74.6, 76 and 86.2% of patients and a seizure freedom in 42.2, 43 and 50%, respectively. The median number of seizures in the 3 months before treatment was 13, and decreased to 3 between baseline and 6 months, and to 0.5 between 6 and 9 months. The best seizure response was observed at 3 months (62%). Sixty per cent of patients displayed the maximum seizure control with doses of lacosamide of 100–250 mg/day, while 21% needed doses up to 400 mg/day. Seizure reduction ≥ 50% and seizure freedom were higher in patients who received lacosamide as first add-on compared to those who received a later adjunctive therapy. A reduction ≥ 50% of seizures was observed in a proportion of patients with progressive disease on MRI. Age > 45 years (OR 0.11, 95% CI 0.02–0.63, p = 0.013) was a significant predictor of seizure freedom at 9 months on multivariate analysis. The study suggests that lacosamide, when added to any baseline AEDs, is effective in obtaining a high seizure reduction and seizure freedom regardless of the tumor activity and response to antineoplastic therapies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. van Breemen MS, Wilms EB, Vecht CJ (2007) Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management. Lancet Neurol 6:421–430. doi:10.1016/S1474-4422(07)70103-5

    Article  PubMed  Google Scholar 

  2. Rudà R, Trevisan E, Soffietti R (2010) Epilepsy and brain tumors. Curr Opin Oncol 22:611–620. doi:10.1097/CCO.0b013e32833de99d

    Article  PubMed  Google Scholar 

  3. Weller M, Stupp R, Wick W (2012) Epilepsy meets cancer: when, why, and what to do about it? Lancet Oncol 13:e375–382. doi:10.1016/S1470-2045(12)70266-8

    Article  Google Scholar 

  4. Armstrong TS, Grant R, Gilbert MR et al (2016) Epilepsy in glioma patients: mechanisms, management, and impact of anticonvulsant therapy. Neuro Oncol 18:779–789. doi:10.1093/neuonc/nov269

    Article  PubMed  Google Scholar 

  5. Vecht CJ, Wagner GL, Wilms EB (2003) Treating seizures in patients with brain tumors: drug interactions between antiepileptic and chemotherapeutic agents. Semin Oncol 30:49–52

    Article  CAS  PubMed  Google Scholar 

  6. Rossetti AO, Stupp R (2010) Epilepsy in brain tumor patients. Curr Opin Neurol 23:603–609. doi:10.1097/WCO.0b013e32833e996c

    Article  CAS  PubMed  Google Scholar 

  7. Rudà R, Bello L, Duffau H et al (2012) Seizures in low-grade gliomas: natural history, pathogenesis, and outcome after treatments. Neuro Oncol 14(Suppl 4):iv55–iv64 doi:10.1093/neuonc/nos199

    Article  PubMed  PubMed Central  Google Scholar 

  8. Hildebrand J, Lecaille C, Perennes J et al (2005) Epileptic seizures during follow-up of patients treated for primary brain tumors. Neurology 65:212–215. doi:10.1212/01.wnl.0000168903.09277.8f

    Article  PubMed  Google Scholar 

  9. Rudà R, Soffietti R (2015) What is new in the management of epilepsy in gliomas? Curr Treat Options Neurol 17:351. doi:10.1007/s11940-015-0351-8

    Article  PubMed  Google Scholar 

  10. Vecht CJ, Kerkhof M, Duran-Pena A (2014) Seizure prognosis in brain tumors: new insights and evidence-based management. Oncologist 19:751–759. doi:10.1634/theoncologist.2014-0060

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Beydoun A, D’Souza J, Hebert D et al (2009) Lacosamide: pharmacology, mechanisms of action and pooled efficacy and safety data in partial-onset seizures. Expert Rev Neurother 9:33–42. doi:10.1586/14737175.9.1.33

    Article  CAS  PubMed  Google Scholar 

  12. Scott LJ (2015) Lacosamide: a review in focal seizures in patients with epilepsy. Drugs 75:2143–2154. doi:10.1007/s40265-015-0514-7

    Article  CAS  PubMed  Google Scholar 

  13. Maschio M, Dinapoli L, Mingoia M et al (2011) Lacosamide as add-on in brain tumor-related epilepsy: preliminary report on efficacy and tolerability. J Neurol 258:2100–2104. doi:10.1007/s00415-011-6132-8

    Article  CAS  PubMed  Google Scholar 

  14. Saria MG, Corle C, Hu J et al (2013) Retrospective analysis of the tolerability and activity of lacosamide in patients with brain tumors: clinical article. J Neurosurg 118:1183–1187. doi:10.3171/2013.1.JNS12397

    Article  CAS  PubMed  Google Scholar 

  15. Wen PY, Macdonald DR, Reardon DA et al (2010) Updated response assessment criteria for high-grade gliomas: response assessment in neuro-oncology working group. J Clin Oncol 28:1963–1972. doi:10.1200/JCO.2009.26.3541

    Article  PubMed  Google Scholar 

  16. van den Bent MJ, Wefel JS, Schiff D et al (2011) Response assessment in neuro-oncology (a report of the RANO group): assessment of outcome in trials of diffuse low-grade gliomas. Lancet Oncol 12:583–593. doi:10.1016/S1470-2045(11)70057-2

    Article  PubMed  Google Scholar 

  17. Basch E, Iasonos A, McDonough T et al (2006) Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events: results of a questionnaire-based study. Lancet Oncol 7:903–909. doi:10.1016/S1470-2045(06)70910-X

    Article  PubMed  Google Scholar 

  18. Jaeckle KA, Ballman K, Furth A et al (2009) Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma. Neurology 73:1207–1213. doi:10.1212/WNL.0b013e3181bbfeca

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Avila EK, Chamberlain M, Schiff D et al (2017) Seizure control as a new metric in assessing efficacy of tumor treatment in low-grade glioma trials. Neuro Oncol 19:12–21. doi:10.1093/neuonc/now190

    Article  PubMed  Google Scholar 

  20. Kerkhof M, Dielemans JC, van Breemen MS et al (2013) Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme. Neuro Oncol 15:961–967. doi:10.1093/neuonc/not057

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Villanueva V, Lopez FJ, Serratosa JM et al (2013) Control of seizures in different stages of partial epilepsy: LACO-EXP, a Spanish retrospective study of lacosamide. Epilepsy Behav 29:349–356. doi:10.1016/j.yebeh.2013.07.024

    Article  PubMed  Google Scholar 

  22. Runge U, Arnold S, Brandt C et al (2015) A noninterventional study evaluating the effectiveness and safety of lacosamide added to monotherapy in patients with epilepsy with partial-onset seizures in daily clinical practice: the VITOBA study. Epilepsia 56:1921–1930. doi:10.1111/epi.13224

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Zadeh WW, Escartin A, Byrnes W et al (2015) Efficacy and safety of lacosamide as first add-on or later adjunctive treatment for uncontrolled partial-onset seizures: a multicentre open-label trial. Seizure 31:72–79. doi:10.1016/j.seizure.2015.07.001

    Article  PubMed  Google Scholar 

  24. van Breemen MS, Rijsman RM, Taphoorn MJ et al (2009) Efficacy of anti-epileptic drugs in patients with gliomas and seizures. J Neurol 256:1519–1526. doi:10.1007/s00415-009-5156-9

    Article  PubMed  Google Scholar 

  25. Rosati A, Tomassini A, Pollo B et al (2009) Epilepsy in cerebral glioma: timing of appearance and histological correlations. J Neurooncol 93:395–400. doi:10.1007/s11060-009-9796-5

    Article  PubMed  Google Scholar 

  26. Kaloshi G, Benouaich-Amiel A, Diakite F et al (2007) Temozolomide for low-grade gliomas: predictive impact of 1p/19q loss on response and outcome. Neurology 68:1831–1836. doi:10.1212/01.wnl.0000262034.26310.a2

    Article  CAS  PubMed  Google Scholar 

  27. Sherman JH, Moldovan K, Yeoh HK et al (2011) Impact of temozolomide chemotherapy on seizure frequency in patients with low-grade gliomas. J Neurosurg 114:1617–1621. doi:10.3171/2010.12.JNS101602

    Article  PubMed  Google Scholar 

  28. Rudà R, Magliola U, Bertero L et al (2013) Seizure control following radiotherapy in patients with diffuse gliomas: a retrospective study. Neuro Oncol 15:1739–1749. doi:10.1093/neuonc/not109

    Article  PubMed  PubMed Central  Google Scholar 

  29. Koekkoek JA, Dirven L, Heimans JJ et al (2016) Seizure reduction is a prognostic marker in low-grade glioma patients treated with temozolomide. J Neurooncol 126:347–354. doi:10.1007/s11060-015-1975-y

    Article  CAS  PubMed  Google Scholar 

  30. Koekkoek JA, Dirven L, Heimans JJ et al (2015) Seizure reduction in a low-grade glioma: more than a beneficial side effect of temozolomide. J Neurol Neurosurg Psychiatry 86:366–373. doi:10.1136/jnnp-2014-308136

    Article  PubMed  Google Scholar 

  31. Lang N, Lange M, Schmitt FC et al (2016) Intravenous lacosamide in clinical practice—results from an independent registry. Seizure 39:5–9. doi:10.1016/j.seizure.2016.01.008

    Article  PubMed  Google Scholar 

  32. Mnatsakanyan L, Chung JM, Tsimerinov EI et al (2012) Intravenous Lacosamide in refractory nonconvulsive status epilepticus. Seizure 21:198–201. doi:10.1016/j.seizure.2011.12.008

    Article  CAS  PubMed  Google Scholar 

  33. Biton V, Gil-Nagel A, Isojarvi J et al (2015) Safety and tolerability of lacosamide as adjunctive therapy for adults with partial-onset seizures: analysis of data pooled from three randomized, double-blind, placebo-controlled clinical trials. Epilepsy Behav 52:119–127. doi:10.1016/j.yebeh.2015.09.006

    Article  PubMed  Google Scholar 

  34. Steinhoff BJ, Eckhardt K, Doty P et al (2016) A long-term noninterventional safety study of adjunctive lacosamide therapy in patients with epilepsy and uncontrolled partial-onset seizures. Epilepsy Behav 58:35–43. doi:10.1016/j.yebeh.2016.02.041

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Neuro-Oncology, University and City of Health and Science Hospital, via Cherasco 15, 10126, Turin, Italy

    Roberta Rudà, Alessia Pellerino, Federica Franchino, Cinzia Bertolotti, Francesco Bruno, Francesca Mo & Riccardo Soffietti

  2. Unit of Cancer Epidemiology (CPO Piemonte) and University of Turin, Turin, Italy

    Enrica Migliore & Gianni Ciccone

Authors
  1. Roberta Rudà
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Alessia Pellerino
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Federica Franchino
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Cinzia Bertolotti
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Francesco Bruno
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Francesca Mo
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Enrica Migliore
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Gianni Ciccone
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Riccardo Soffietti
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Roberta Rudà.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOCX 21 KB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rudà, R., Pellerino, A., Franchino, F. et al. Lacosamide in patients with gliomas and uncontrolled seizures: results from an observational study. J Neurooncol 136, 105–114 (2018). https://doi.org/10.1007/s11060-017-2628-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-017-2628-0

Keywords

Search

Navigation